blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2245022

EP2245022 - ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.01.2013
Database last updated on 05.10.2024
Most recent event   Tooltip11.01.2013Application deemed to be withdrawnpublished on 13.02.2013  [2013/07]
Applicant(s)For all designated states
Panmira Pharmaceuticals, LLC
9535 Waples Street, Suite 100
San Diego, CA 92121 / US
[2011/48]
Former [2010/44]For all designated states
Amira Pharmaceuticals, Inc.
9535 Waples Street, Suite 100
San Diego, CA 92121 / US
Inventor(s)01 / HUTCHINSON, John Howard
3435 Richmond Street
San Diego CA 92103 / US
02 / STEARNS, Brian Andrew
157 Beechtree Drive
Encinatas CA 92024 / US
03 / SEIDERS, Thomas Jon
5257 Soledad Mountain Road
San Diego California 92109 / US
04 / SCOTT, Jill Melissa
456 Birmingham Drive
Cardiff California 92007 / US
05 / ARRUDA, Jeannie M.
3611 Florida St. 4
San Diego California 92104 / US
06 / WANG, Bowei
10 Kirkview Circle
Westfield NJ 07090 / US
 [2010/44]
Representative(s)Cole, William Gwyn, et al
Avidity IP
Broers Building
Hauser Forum
21 J J Thomson Avenue
Cambridge CB3 0FA / GB
[N/P]
Former [2010/44]Cole, William Gwyn, et al
HLBBshaw Merlin House Falconry Court Baker's Lane
GB-Epping, Essex CM16 5DQ / GB
Application number, filing date09715996.625.02.2009
[2010/44]
WO2009US35174
Priority number, dateUS2008003131025.02.2008         Original published format: US 31310
[2010/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009108720
Date:03.09.2009
Language:EN
[2009/36]
Type: A2 Application without search report 
No.:EP2245022
Date:03.11.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 03.09.2009 takes the place of the publication of the European patent application.
[2010/44]
Search report(s)International search report - published on:KR05.11.2009
(Supplementary) European search report - dispatched on:EP19.01.2012
ClassificationIPC:C07D285/04, C07D291/04, C07D275/03, A61P29/00, A61P37/08, C07D233/06, C07D263/22, C07D263/52
[2012/08]
CPC:
C07D285/04 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P11/06 (EP);
A61P11/08 (EP); A61P11/10 (EP); A61P11/14 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P27/02 (EP); A61P27/16 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D233/06 (EP,US); C07D263/22 (EP,US);
C07D263/52 (EP,US) (-)
Former IPC [2010/44]C07D285/04, C07D291/04, C07D275/03, A61P29/00, A61P37/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/44]
Extension statesAL24.08.2010
BA24.08.2010
RS24.08.2010
TitleGerman:ANTAGONISTEN VON PROSTAGLANDIN-D2-REZEPTOREN[2010/44]
English:ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS[2010/44]
French:ANTAGONISTES DES RÉCEPTEURS D2 DE LA PROSTAGLANDINE[2010/44]
Entry into regional phase24.08.2010National basic fee paid 
24.08.2010Search fee paid 
24.08.2010Designation fee(s) paid 
24.08.2010Examination fee paid 
Examination proceduredeletedCommunication of intention to grant the patent
24.08.2010Examination requested  [2010/44]
14.10.2010Amendment by applicant (claims and/or description)
18.08.2012Application deemed to be withdrawn, date of legal effect  [2013/07]
27.09.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/07]
Fees paidRenewal fee
23.02.2011Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
29.02.201204   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO2004094372  (SQUIBB BRISTOL MYERS CO [US], et al) [X] 1,2,11-15 * Ex. 11, title compound; ex. 11, intermediate of step C; paragraph [0368]; claim 1 * [I] 1,2,11-15;
 [A]WO2006037982  (ASTRAZENECA AB [SE], et al) [A] 1-15 * the whole document *;
 [A]WO2007047378  (AVENTIS PHARMA INC [US], et al) [A] 1-15 * the whole document *
International search[X]US2004214888  (MATSUURA FUMIYOSHI [JP], et al);
 [A]JP2004182657  (EISAI CO LTD);
 [X]WO0149288  (MERCK FROSST CANADA INC [CA], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.